March 27, 2020: Aquavit Pharmaceuticals, Inc. Announces Filing of New Patent Applications for a New Drug Delivery Platform and Vaccine Compositions for Immun...

June 3, 2019: New York, NY New York-based Aquavit Pharmaceuticals, Inc. is delighted to introduce Dr. Jill Waibel as its new Chief Medical Officer (CMO). Jil...

June 3, 2019: New York, NY Aquavit Pharmaceuticals, Inc. announced today that Chief Executive Officer Sobin Chang will be presenting at the BIO International...

Seoul, South Korea May 28, 2019 – Aquavit Life Sciences, Inc. today received an official notice from the police that they have requested indictment of Corea ...

NEW YORK, April 29, 2019 – Aquavit Pharmaceuticals, Inc. secured a Preliminary Injunction Order in the United States District Court for the Southern District...

March 4, 2019 Dear Valued Customers: It has come to our attention that an illegal Korean operator has been falsely advertising as if they are manufacturing A...

SEOUL, Nov.13, 2017 / South Korea/ — Aquavit Life Sciences, Inc. (Aquavit) is pleased to announce the acquisition of Korean manufacturing company Hail Co. Lt...

New York, NEW YORK, September 1, 2017 Aquavit Pharmaceuticals, Inc. announced that the United States Patent and Trademark Office (USPTO) has issued a patent ...

Las Vegas, NEVADA, August 31, 2017 Aquavit pharmaceuticals announced today that it has received a green light from the IRB, to conduct in-depth research for ...

PIRACY ALERT October 21, 2016 Dear Valued Customers and Partners of Aquavit: RE: Illegal Piracy Activities in Korea and China It has come to our attention th...

NEW YORK, May 30, 2015 /USA/ — Aquavit Pharmaceuticals Inc. (Aquavit) is pleased to announce that it has officially registered its fluid injecting apparatus w...

New York, NEW YORK, November 4, 2014 Aquavit Pharmaceuticals welcomes Mary Lupo, MD, FAAD as its newest Scientific Advisory Board member. Dr. Lupo is a board...

Denver, COLORADO, March 23, 2014 Aquavit Pharmaceuticals, Inc., a New York-based technology-driven life science company, officially launched its cutting-edge...

New York City, NEW YORK, March 5, 2014 Aquavit Pharmaceuticals, Inc., a private high-tech life science company, announced today the appointment of David J. G...

Miami Beach, Florida, February 17, 2014 AQUAGOLD® fine touch™ was presented at the 2014 South Beach Symposium in Miami during a session on “What is New in De...

Paris, France, February 5, 2014 AQUAGOLD® fine touch™ was featured at the 2014 International Master Course on Aging Skin Conference (IMCAS) in Paris during a...

Kohala Coast, HAWAII, January 19, 2014 AQUAGOLD® fine touch™ was featured at the 2014 Winter Clinical Dermatology Conference in Hawaii during a session on “N...

NEW YORK, Nov. 5, 2013 Aquavit Pharmaceuticals, Inc. has further extended its personalized drug delivery platform by signing a binding preliminary agreement w...

NEW YORK, March 4, 2013 Aquavit Pharmaceuticals Inc. has announced its newest addition to its management team, Dr. David Shafer . He has been appointed Chief...

SEOUL & NEW YORK, January 21, 2013 We are pleased to announce that Dr. B.G. Rhee has signed on as a member of Aquavit Pharmaceutical’s Advisory Board. The hi...